Entera Bio Ltd
NASDAQ:ENTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entera Bio Ltd
NASDAQ:ENTX
|
IL |
|
CubicFarm Systems Corp
TSX:CUB
|
CA |
|
CapitaLand Ascott Trust
OTC:ATTRF
|
SG |
|
Logitech International SA
NASDAQ:LOGI
|
CH |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
Arch Capital Group Ltd
NASDAQ:ACGL
|
BM |
|
M K Proteins Ltd
NSE:MKPL
|
IN |
|
FLEX LNG Ltd
OSE:FLNG
|
BM |
|
V
|
Vertu Capital Ltd
LSE:VCBC
|
MY |
|
D
|
Doms Industries Ltd
NSE:DOMS
|
IN |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
Middlefield Banc Corp
NASDAQ:MBCN
|
US |
|
I
|
Interwood Xylemboria ATENE
ATHEX:XYLEK
|
GR |
|
G
|
Greek Organisation of Football Prognostics SA
ATHEX:OPAP
|
GR |
|
H
|
Hong Leong Capital Bhd
KLSE:HLCAP
|
MY |
|
V
|
Valencia Capital Inc
XTSX:VAL.P
|
CA |
|
A
|
American CuMo Mining Corp
XTSX:MLY
|
CA |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
Bankruptcy Probability
Entera Bio Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Entera Bio Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Entera Bio Ltd
NASDAQ:ENTX
|
57.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Entera Bio Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Entera Bio Ltd has no debt.
You can find a full breakdown on its Balance Sheet.